Aetion
Sebastian Schneeweiss is a distinguished academic and medical professional serving as a Professor of Medicine and Epidemiology at Harvard Medical School and Chief of the Division of Pharmacoepidemiology in the Department of Medicine at Brigham and Women's Hospital. Schneeweiss is also a Co-Founder of Aetion, Inc. and has held the position of Visiting Fellow at the Center for Advanced Studies at LMU Munich. Schneeweiss earned a Doctor of Science (Sc.D.) in Pharmacoepidemiology from Harvard T.H. Chan School of Public Health and completed the Brigham Leadership Program in Health Care Administration and Management at Harvard Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Aetion
9 followers
Aetion is a health care technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on treatments, costs, and outcomes. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide treatment development, commercialization, and payment innovation into health care’s modern era.